微生物组诊断:方法、挑战与临床转化前景
该综述概述了微生物组诊断应用的方法、挑战与考量,涵盖从16S rRNA扩增子测序到宏基因组学和宏转录组学的方法学演变。为提升可重复性,需标准化检测流程中最脆弱的步骤并持续定义质控标准,试剂纯度、参考数据库改进及诊断级数据分析方案需跨学科与制造商共同努力。未来十年微生物组诊断有望在诊断实验室落地并应用于常规医疗实践。
要点
- 微生物组诊断方法从16S rRNA扩增子测序向宏基因组学和宏转录组学演进。
- 提升可重复性需标准化检测流程中最脆弱步骤并持续定义质控标准。
- 试剂纯度、参考数据库和诊断级数据分析方案是当前关键挑战。
核心结论
- 微生物组诊断有望在未来十年于诊断实验室实施并应用于常规医疗实践。
研究设计与样本
- 本综述概述微生物组诊断应用的方法、挑战与考量,借鉴分子诊断其他领域包括临床宏基因组学的经验。
主要发现
- 过去十年测序技术与计算生物学突破为研究人体微生物群落影响健康与疾病提供了基础。
- 几乎所有医学专科对微生物组准确且可重复的分析用于诊断和治疗应用的兴趣日益增长。
- 支持不同解剖部位微生物组与人类健康疾病重要关联的文献正快速增加,肠道微生物组的治疗性操作正变得常规。
关键数值与推荐
- 为提升可重复性,至少检测流程中最脆弱的步骤需标准化,并需持续努力定义质控标准。
- 试剂与耗材纯度、参考数据库改进及诊断级数据分析方案的可用性需跨学科与制造商共同努力。
临床怎么用
- 微生物组诊断未来可在诊断实验室实施,以充分利用技术与科学进展并应用于常规医疗实践。
局限性
- 试剂与耗材纯度、参考数据库改进及诊断级数据分析方案的可用性等挑战需跨学科与制造商共同努力解决。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During the past decade, breakthroughs in sequencing technology and computational biology have provided the basis for studies of the myriad ways in which microbial communities ("microbiota") in and on the human body influence human health and disease. In almost every medical specialty, there is now a growing interest in accurate and replicable profiling of the microbiota for use in diagnostic and therapeutic application. CONTENT: This review provides an overview of approaches, challenges, and considerations for diagnostic applications borrowing from other areas of molecular diagnostics, including clinical metagenomics. Methodological considerations and evolving approaches for microbiota profiling from mitochondrially encoded 16S rRNA-based amplicon sequencing to metagenomics and metatranscriptomics are discussed. To improve replicability, at least the most vulnerable steps in testing workflows will need to be standardized and continuous efforts needed to define QC standards. Challenges such as purity of reagents and consumables, improvement of reference databases, and availability of diagnostic-grade data analysis solutions will require joint efforts across disciplines and with manufacturers. SUMMARY: The body of literature supporting important links between the microbiota at different anatomic sites with human health and disease is expanding rapidly and therapeutic manipulation of the intestinal microbiota is becoming routine. The next decade will likely see implementation of microbiome diagnostics in diagnostic laboratories to fully capitalize on technological and scientific advances and apply them in routine medical practice.
引用
- Schlaberg R. Microbiome Diagnostics. Clin Chem. 2020. PMID: 31843867. doi:10.1373/clinchem.2019.303248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。